Diaxonhit (NYSE Alternext, FR0004054427, ALEHT) is a French fully integrated leader in in vitro diagnostics, involved from research to commercialization of specialty diagnostic products in the fields of transplantation, infectious diseases and cancer.
With many partnerships and a strong presence in hospitals, Diaxonhit has an extensive commercialization network. Through its affiliate, InGen, it commercializes and services, mostly under exclusivity agreements, in-vitro diagnostic kits and advanced equipment, quality control products and rapid tests, including Tetanus Quick Stick ®, a proprietary product. InGen is the leading supplier in France of HLA tests manufactured by Thermo-Fisher/One Lambda,of which it is the largest commercial partner worldwide.
The group also owns a diversified portfolio of products in development, including both innovative molecular and non-molecular diagnostics, covering its three main specialty areas: transplantation, immuno-infection and cancer.
Diaxonhit headquarters are located in Paris and its affiliate in the Paris region. The Group is listed on NYSE Alternext in Paris and is part of both the NYSE Alternext OSEO Innovation and the Next Biotech indices.
Symbol : ALEHT - ISIN Code: FR0004054427 - Reuters : ALEHT.PA - Bloomberg : ALEHT:FP
Company Details
- Employees
- 24
- Founded
- -
- Address
- 63-65 Boulevard Massena, Paris,75013,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.diaxonhit.com
- HQ
- Paris
Diaxonhit Questions
Diaxonhit's website is http://www.diaxonhit.com
Diaxonhit's LinkedIn profile is https://www.linkedin.com/company/exonhit-therapeutics
Diaxonhit has
24 employees.
View email and phone details for 24
employees at Diaxonhit.
Diaxonhit's industry is
Biotechnology Research
Diaxonhit's top competitors are
Myrfidsolution,
Nomad Bioscience Gmbh,
Biomérieux,
Patrick Lee & Associates,
Tme Pharma,
Ortho Clinical Diagnostics,
Vagus Health Ltd.,
Isofol Medical Ab (Publ),
Upsa,
Dna Script.
Diaxonhit's categories are Biotechnology Research
Diaxonhit's founding year is 1997
